Exparel + Bupivacaine

DRUG2 trials

Sponsors

Pacira Pharmaceuticals, Inc, George Washington University

Conditions

C-SectionFractureFracture Dislocation of Ankle JointFracture FemurFracture LegFracture Lower LegPain Management

Phase 4

Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the TAP vs. Bupivacaine Alone in Subjects Undergoing Elective C-Sections

CompletedNCT03176459

Pacira Pharmaceuticals, IncC-Section, Pain Management

Start: 2017-06-01End: 2018-12-04Updated: 2021-01-06

Single Shot Exparel vs Catheters in Lower Extremity Trauma

RecruitingNCT07221019

George Washington UniversityFracture, Fracture Dislocation of Ankle Joint, Fracture Femur +2

Start: 2025-09-12End: 2029-08-11Target: 90Updated: 2025-10-28

Related Papers

Transversus Abdominis Plane Block With Liposomal Bupivacaine for Pain After Cesarean Delivery in a Multicenter, Randomized, Double-Blind, Controlled Trial

Anesthesia & Analgesia2020-07-2199 citations